Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Overview
DESCRIPTION | |
Species Reactivity | Human,mouse and rat. Other species not tested. |
Immunogen | A peptide near the C terminal of human CCND1 (G1/S-specific cyclin-D1; BCL-1; BCL-1 oncogene; PRAD1 oncogene; BCL1; PRAD1). Accession# P24385 |
Purification | Purified by peptide affinity column |
Formulation | Lyophilized with 1% BSA and 0.02% NaN3. |
Size | 100ug/200µl |
PREPARATION AND STORAGE | |
Reconstitution | Reconstitute in 200µl of sterile H2O. |
Storage | Shipped at ambient temperature. Store immediately at -20°C upon receipt. Avoid repeated freeze-thaw cycles. |
REFERENCES |
| Vijayalakshmi, N., Selvaluxmi, G., Majhi, U, et al. Alterations found in pl6/Rb/cyclin D1 pathway in the dysplastic and malignant cervical epithelium. Oncol. Res. 2007 :16 (11):527-533. |